CIDRAP newsletters options
A study of antibodies in 48 people in Saudi Arabia who survived their MERS-CoV infections found that some neutralizing antibodies persisted 6 years, a Saudi-led team reported yesterday in Emerging Infectious Diseases.
PAHO's director says South America continues to be an epicenter but is not acting like it by easing mitigations steps.
"Exercise is medicine that everyone should take—especially in this era of COVID-19."
ACIP experts will gather more data and likely meet again in 7 to 10 days.
A pilot trial conducted at two emergency departments (EDs) found that audit and feedback with peer-to-peer comparisons reduced antibiotic prescribing for viral acute respiratory infections (ARIs) but not overall antibiotic use, researchers reported today in Open Forum Infectious Diseases.
Keeping middle seats vacant on air flights has the potential to cut transmission of virus particles by 57% when multiple passengers are infected and by 23% when a single passenger is infected, according to an aerosol dispersion study that included earlier data that modeled plane airflow.
"Right now I'd like to stress these events seem to be extremely rare," says Janet Woodcock, acting FDA commissioner.
Studies find that antibodies pass robustly from mothers to infants in breast milk.
Spikes continue in hot spots like Iran and Japan as the global death toll nears 3 million.
Overall and respiratory tract infection (RTI)-specific antibiotic prescribing fell significantly in British Columbia during the first few months of the COVID-19 pandemic, according to a study today in Open Forum Infectious Diseases.
The COVID-19 pandemic has negatively affected healthcare programs in low- and middle-income countries (LMICs) that work to protect populations against HIV, tuberculosis (TB), and malaria, according to a new report by the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
"If we tried to vaccinate our way out of what is happening in Michigan, we would be disappointed that it took so long," says CDC director.
Officials say masks, distancing, and other measures are needed to give vaccines a chance to succeed.
COVID-19 survivors also had a 93% lower risk of symptomatic infection within 7 months.
A study of Veterans Affairs (VA) hospitals found that prospective audit and feedback (PAF) and prior-approval strategies focused on fluoroquinolone use were associated with lower fluoroquinolone prescribing rates, US researchers reported today in Infection Control & Hospital Epidemiology.
One dose of the Pfizer/BioNTech COVID-19 vaccine appears to be not very protective against the B117 variant, and two doses may not be as effective against the B1351 variant, according to a non–peer-reviewed, real-world Israeli study posted late last week on the medRxiv preprint server.
Also, UK advisors urge people younger than 30 to get a vaccine other than AstraZeneca when available.
Patients in 3 European nations developed an unusual blood clotting disorder.
Studies spotlight disease impact in Montana and control efforts in two states.
Jeff Zients says, "Now is not the time to change course on vaccine allocation,” as some states report dramatic spikes.
